Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Grand River Has Come a Long Way
N
Nice Insight
Apr 12, 2017
PTV-M11-16-AP-026
CDMO
Biologics - Large Molecule
PA TV (video)
Tom Ross, President and CEO, Grand River
Related Content
Sustainability
How is sustainability shifting from a reporting exercise to a design constraint in manufacturing and development?
Pharma's Almanac
PAO-10-26-RT-01
Oct 30, 2026
Antibody Data
Does Antibody Development Have a Data Problem?
Sophie Lutter, Ph.D.
Lab Thread
PAO-10-26-CL-08
Oct 26, 2026
Cell Therapy
Overcoming Formulation and Fill/Finish Challenges for Cell Therapies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-26-PA-15
Oct 26, 2026
Orthogonal Methods
Orthogonal Analytics: How Much Characterization Is Enough?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-14
Oct 22, 2026
SmartScale
Phase-Appropriate CMC Requires a New Phase-Appropriate Manufacturing Model
Jesse McCool, Ph.D.
GBI Biomanufacturing
PAO-10-26-CL-05
Oct 21, 2026
Data-Driven Mfg
Data-Driven Manufacturing and Digital Twins Across the Biologics Network
Jihyeon Oh; Hongwoo Joo
Samsung Biologics
PAO-10-26-CL-03
Oct 21, 2026
Flow Chemistry
When Flow Chemistry Solves the Manufacturing Problem
Hiroaki Yasukouchi, Ph.D.
Kaneka
PAO-10-26-CL-04
Oct 20, 2026
ASDs
The Evolving Science of Amorphous Solid Dispersions
Pharma's Almanac
PAO-10-26-PA-13
Oct 20, 2026
CLD
Can Mammalian Cell-Line Engineering Become a High-Throughput Design Problem?
Pharma's Almanac
PAO-10-26-PA-09
Oct 14, 2026
Bioprocessing
Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-26-PA-06
Oct 9, 2026
Pathfinder
Solid-Phase vs. Liquid-Phase Peptide Synthesis: Which Manufacturing Strategy Is Better?
Nice Insight
PAO-26-PF-28
Oct 9, 2026
Formulation Models
Predictive Formulation: Can Modeling Reduce Empirical Development?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-04
Oct 7, 2026
Previous slide
Next slide